The lumped constant in the operational equa tion of the 2-[14C]deoxyglucose (DG) method contains the factor A that represents the ratio of the steady-state tissue distribution spaces for [14C]DG and glucose. The lumped constant has been shown to vary with arterial plasma glucose concentration. Predictions based mainly on theo retical grounds have suggested that disproportionate changes in the distribution spaces for [14C]DG and glU cose and in the value of A are responsible for these vari ations in the lumped constant. The influence of arterial plasma glucose concentration on the distribution spaces for DG and glucose and on A were, therefore, determined in the present studies by direct chemical measurements. The brain was maintained in steady states of delivery and metabolism of DG and glucose by programmed intraveThe lumped constant of the deoxyglucose (DG) method (Sokoloff et al. , 1977) is a proportionality factor that converts the rate of DG phosphorylation by hexokinase to the net rate of glucose utilization. It is a combination of factors that, under the re quired steady-state conditions of the method, can be expected to remain constant with time through out the experimental period, but not necessarily from species to species, organ to organ, and in a given organ and species from condition to condi- Abbreviations used: DG, 2-deoxY-D-glucose; G-6-P, D glucose-6-phosphate; G-6-Pase, glucose-6-phosphatase.
The lumped constant of the deoxyglucose (DG) method (Sokoloff et al. , 1977 ) is a proportionality factor that converts the rate of DG phosphorylation by hexokinase to the net rate of glucose utilization. It is a combination of factors that, under the re quired steady-state conditions of the method, can be expected to remain constant with time through out the experimental period, but not necessarily from species to species, organ to organ, and in a given organ and species from condition to condi-nous infusions of both hexoses designed to produce and maintain constant arterial concentrations. Hexose con centrations were assayed in acid extracts of arterial plasma and freeze-blown brain. Graded hyperglycemia up to 28 mM produced progressive decreases in the distri bution spaces of both hexoses from their normoglycemic values (e.g., --20% for glucose and -50% for DG at 28 mM) . In contrast, graded hypoglycemia progressively re duced the distribution space for glucose and increased the space for [14C]DG. The values for A were comparatively stable in normoglycemic and hyperglycemic conditions but rose sharply (e.g., as much as 9-lO-fold at 2 mM) in severe hypoglycemia. Key Words: Cerebral glucose use Brain metabolism-Hypoglycemia-Hyperglycemia Hexose distribution space.
tion. One factor, <1>, is a constant between 0 and 1 that takes into account the relative rates of phos phorylation of glucose and dephosphorylation of D glucose-6-phosphate (G-6-P); in the absence of any significant G-6-P dephosphorylation, <I> is essen tially equal to 1 and can be disregarded as a possible source of state-dependent variation in the value of the lumped constant in brain, except, perhaps, in pathological tissue in which intracellular compart mentation has been disrupted. A second factor, V�Km/V mK� , the phosphorylation coefficient (Sols and Crane, 1954) , accounts for the relative kinetic properties of hexokinase with respect to the phos phorylation of DG and glucose; it is a property of the species of the hexokinase and may, therefore, vary with the species and organ but because it con sists of the ratios of the kinetic constants can be expected to remain stable with time or condition in brain (Thompson and Bachelard, 1970; Purich et aI., 1973; Sokoloff et aI. , 1977; Wilson, 1985) . The last factor is x., the ratio of the effective steady-state tissue distribution space for DG to that of glucose. The fact that it is a ratio of the distribution spaces for the two hexoses tends to confer some stability to the value of X. with changing conditions but does not ensure it. X. is equal to [Kj/(k! + kj))/[K/(k2 + k3)), where Kj and K 1 are the transfer constants for the carrier-mediated transport of DG and glucose, re spectively, from plasma to brain tissue, k! and k2 are the corresponding rate constants for their trans port back from brain to plasma, and kj and k3 are the respective rate constants for their phosphoryla tion by hexokinase. Inasmuch as the values for these rate constants are influenced by blood flow, blood-brain barrier transport, and metabolism, all functions that can readily change from condition to condition, it can be expected that X. can be a source of state-dependent variation of the lumped constant in brain.
Theoretical considerations of the balance be tween transport of DG and glucose across the blood-brain barrier and their phosphorylation in brain have led to predictions that the value of X. could change considerably whenever delivery of glucose cannot keep pace with its rate of use, e. g., when glucose concentration in the tissue falls ap preciably because of inadequate delivery to the tis sue or excessive utilization (Gjedde, 1982; Par dridge, 1983) . Knowledge of the tissue concentra tion of glucose could make it possible to quantify the change in X. (Cunningham and Cremer, 1981; Gjedde, 1982; Pardridge, 1983) . Experimental de terminations of the lumped constant have shown that it is relatively constant under physiological conditions but that it does indeed change when the balance between glucose delivery and use is seri ously altered. For example, the lumped constant in rat brain remains reasonably stable over a range of arterial plasma glucose concentrations between 4 and 12-13 mM (Pettigrew et aI. , 1983) , falls very gradually in hyperglycemia above this level, --20% at 33 mM (Schuier et aI. , 1981) , but rises markedly and progressively with increasing hypo glycemia to >100% at -2 mM (Suda et aI. , 1981) . The very high rates of glucose use in sustained sei zure activity have also been found to increase the value of the lumped constant (Ingvar and Siesjo, 1981; Diemer and Gjedde, 1983) .
In view of the likelihood that these changes in the lumped constant were a consequence of the alter ations in the value of X., the influence of arterial plasma glucose concentration over the entire range from hypoglycemia to hyperglycemia on the steady state tissue:plasma distribution ratios of DG and glucose and on X. were determined by model independent direct chemical measurements. The re sults demonstrate that the changes in the lumped constant previously observed to occur with changes in plasma glucose concentration can be attributed to the changes in the value of X..
MATERIALS AND METHODS

Chemicals
Dowex-l-formate (AG l-X8-formate, 100-200 mesh) ion exchange resin was purchased from Bio-Rad (Richmond, CA, U.S.A.). Hexokinase (E.C. 2.7.1.1) and glucose-6-phosphate dehydrogenase (E.C. (Vomhof and Tucker, 1965) ; the radiochemical purity was found to be �98%.
Animals
Normal, male Sprague-Dawley rats weighing 250-350 g were obtained from Taconic Farms (Germantown, NY, U.S.A.). They were maintained on laboratory chow and water ad libitum but were fasted 12 h immediately before initiation of the experiments to help to stabilize their basal arterial plasma glucose concentrations during the proce dure. In a few rats the celiac ganglia were surgically re moved on the day before the experiment to denervate the adrenal glands and thus minimize stress-dependent in creases in plasma glucose concentration that occurred when the animals were positioned in the brain freeze blowing apparatus before killing (Veech et al., 1973; Wong and Tyce, 1978) . On the day of the experimem, polyethylene catheters were inserted into one femoral ar tery and both femoral veins under light halothane-70% N20 anesthesia. The rats were allowed to recover for approximately 2 h and were kept in fenestrated acrylic cages during the experimental procedure.
Physiological variables
Body temperature was continuously monitored by means of a rectal thermistor connected to an indicating controller and was maintained at 37°C by an automati cally controlled heating lamp (YSI Model 73A, Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A.). MABP was measured with an air-damped mercury ma nometer. Arterial blood pH, P02, and Pc02 were mea sured with a Corning Model 158 pH/Blood Gas Analyzer (Corning Medical and Scientific, Medfield, MA, U.S.A.). Hematocrit, blood pressure, pH, P02, and Pc02 were measured before the infusion of [14C]DG and immediately before killing; rats with physiological variables outside the normal range were excluded from the study.
Induction and maintenance of constant arterial plasma concentrations of glucose and DG Arterial plasma glucose concentrations were clamped at selected levels ranging from hypoglycemia to hyper glycemia by injection of insulin and/or a programmed in fusion of D-glucose. The schedule of the glucose infusion was determined according to the glucose clamp technique of DeFronzo et al. (1979) adapted for use in rats. Briefly, a priming dose of glucose was first infused during a 5-min interval to bring the arterial plasma glucose concentration from its initial level to ± 10% of the desired level, and then a maintenance dose of glucose was continuously infused at a periodically adjusted rate. The infusions were carried out by means of a calibrated peristaltic pump equipped with a manual speed control (LKB 2120 Varioperpex II Pump, LKB-PRODUKTER AB, Stockholm-Bromma, Sweden), and the rate of infusion was adjusted every 20 s during the priming dose and every 5 min during the main tenance dose. The infusate contained 2.5-20% (wt/vo\) D-glucose dissolved in normal saline; the concentration in each experiment depended on the difference between the initial and desired glucose concentrations. The total infu sion volume ranged from 2 to 6 ml for the 75-11O-min duration of the experiment.
Basal arterial plasma glucose levels in the fasted ani mals were in all cases lower than 7 mM (i.e., 125 mg/d\). Levels in the normoglycemic (approximately 7-11 mM, The infusion schedules were determined separately in experiments with animals in the hypoglycemic, normo glycemic, and hyperglycemic ranges produced as de scribed above. After 30 min of a stable arterial plasma glucose concentration at the level desired, a pulse of [14C]DG was injected intravenously, and the arterial plasma [14C]DG disappearance curve was determined during the following 50 min. The disappearance curve was fitted to the sum of three exponential terms, and from the Laplace transform of the fitted equation an infusion schedule designed to produce a constant arterial concen tration of [14C]DG was computed (Patlak and Pettigrew, 1976) . The infusion schedule appropriate to the arterial J Cereb Blood Flow Metab, Vol. 9, No.3, 1989 plasma glucose level was then used in each of the subse quent experiments.
Experimental procedure
After a constant arterial plasma concentration of glu cose had been maintained for 30-40 min by means of the glucose clamp technique, the programmed infusion of [14C]DG was initiated to achieve and maintain a constant arterial plasma [14C]DG concentration for an additional 45 min. The purpose was to achieve steady states of de livery and metabolism for both glucose and [14C]DG in brain. Timed arterial samples were drawn at 5-min inter vals for the assay of glucose and ct4C]DG concentrations to ensure relatively constant concentrations of both. At approximately 45 min after the onset of the [14C]DG in fusion, most rats were lightly anesthetized by the intra venous administration of sodium thiopental « 15 mg/kg for normoglycemic and hyperglycemic rats and 5-10 mg/ kg for hypoglycemic rats during 15 s) to minimize the hyperglycemic effect of the stress associated with the placing of the rats in the freeze-blowing apparatus (Wong and Tyee, 1978) . A few rats in which celiac ganglionec tomy had previously been performed were not anesthe tized. The rats were then quickly positioned and re strained in the freeze-blowing apparatus (Veech et al., 1973) , and samples of arterial blood were immediately withdrawn for measurement of hematocrit, pH, Pcoz, POz, and plasma P4C]DG and glucose concentrations. The rats were then killed by freeze-blowing (Veech et aI., 1973) within 2 min after the injection of the thiopental. The freeze-blown brain and the last two plasma samples were stored at -80°C until extracted and assayed for hexose concentrations.
Measurement of glucose and DG concentrations in plasma
Glucose and ct4C]DG concentrations were measured in plasma of timed blood samples drawn from the femoral artery at 5-min intervals throughout the experiment. Blood withdrawn to flush the catheter of dead space was returned to the rat to minimize blood loss. The plasma was separated from the blood by centrifugation in a Beck man Microfuge (Beckman Instruments, Fullerton, CA, U.S.A.), and glucose concentration in the plasma was measured by the glucose oxidase method in a Beckman Glucose Analyzer II (Beckman Instruments).
[14C]DG concentration in the plasma was measured by liquid scin tillation counting of the 14C (Beckman Model LS 5801, Beckman Instruments) with either external standardiza tion or internal standardization with calibrated [14C]toluene as the internal standard. Rats were excluded from the study if the arterial plasma concentration of ei ther glucose or [14C]DG deviated from the desired con stant level by more than ± 10% during the experimental interval. Representative time courses of arterial plasma glucose and [14C]DG concentrations are illustrated in Fig. 1 .
Tissue extraction and measurement of glucose and DG concentrations
The frozen brains were powdered under liquid nitrogen in a cryostat maintained at --35°C and divided into weighed l00-200-mg portions. Portions were deprotein ized by thawing in 3 vol of 3 M perchloric acid at -12°C, diluting the acid to 0.6 M, and centrifuging to remove precipitated proteins. Samples (50 J.Ll) of plasma obtained 100 120 Oeoxyglucose; ., Rat in restrainer.
immediately before and just after positioning the rats in the freeze-blowing apparatus were diluted with an equal volume of water and deproteinized by addition of 1.0 ml of 0.7 M perchloric acid and centrifugation. All acid ex tracts were neutralized to pH 7.0-7.5 with 2.0 M KOH-0.4 M imidazole-O.4 M potassium acetate within 1 h after addition of acid (Lowry and Passonneau, 1972) . The KCI0 4 precipitates were removed by centrifugation, and the neutralized acid extracts were stored at -SO°C until analyzed. Portions (0.5 ml) of the neutralized acid ex tracts of plasma and brain were applied to 2 ml Dowex I-formate columns (O.S x 5 cm). The columns were washed with 23 ml of water, and samples of the column effluent were assayed for [14C]DG by liquid scintillation counting of the 14C as described above. The glucose con centrations of the neutralized acid extracts were mea sured enzymatically with hexokinase and glucose-6-phosphate dehydrogenase (Lowry and Passonneau, 1972) . The plasma concentrations of glucose and [14C]DG measured before and after positioning in the freeze blower were averaged to calculate the steady-state distri bution ratios for the two hexoses. Note that steady-state distribution ratio and distribution volume are used inter changeably; it is the ratio of brain to plasma concentra tions in the steady state. The value for A was calculated by dividing the steady-state brain:plasma distribution ra tio of [14C]DG by the equivalent distribution ratio of glu cose (Sokoloff et aI., 1977) .
Statistical analysis
Statistical analyses were made by analysis of variance and Dunnett's test for multiple comparisons against a common control or Bonferroni's tests for multiple paired comparisons (Baily, 1977; Zar, 1974) .
RESULTS
Effects of placing and restraining animals in freeze-blowing apparatus
In preliminary experiments it was noted that the arterial plasma glucose and e4C]DG concentrations in normal conscious rats abruptly increased when the animals were positioned in the restrainer of the freeze-blowing apparatus (Veech et aI., 1973) . A rise in plasma or blood glucose level in animals re strained in the freeze-blowing apparatus has been observed previously (Wong and Tyee, 1978) and is presumably due to stress. The increases that oc curred within the 2 min or less needed to position the animals were often sufficient to exceed the lim its of ± 10% of target levels throughout the experi mental period that had been established as the ac ceptable range for clamping of the arterial plasma glucose and [ 1 4C]DG concentrations needed to achieve steady states for the two hexoses in brain. These increases in the plasma hexose concentra tions could be reduced to the acceptable limits by prior (e.g., 24 h earlier) denervation of the adrenal glands by celiac ganglionectomy and/or by light thio pental anesthesia, particularly if the infusion rates of both hexoses were also slightly reduced during the approximately 2 min needed to position the rats. All of the experiments were carried out with rats in the conscious state through the entire procedure ex cept for the final 2 min when they were positioned in the apparatus. Nine normoglycemic animals had their celiac ganglia removed the day before; six were conscious, and three were lightly anesthetized with thiopental when placed in the freeze-blowing apparatus and killed. The six other normoglycemic rats had not had the celiac ganglionectomies but were anesthetized with thiopental during the place ment and killing. The results were similar in all three subgroups of the normoglycemic rats (Figs.  2-5 ). All rats studied in the hyperglycemic and hy poglycemic ranges were also without celiac gangli onectomies and were lightly anesthetized with thio pental during the approximately 2-min period for positioning in the freeze-blowing apparatus and kill ing.
Physiological variables
Body temperature, hematocrit, and arterial blood pressure, Po 2 , Peo 2 , and pH were measured imme diately before initiation of the e4C]DG infusion and just after the rats were anesthetized with thiopental and positioned in the freeze-blowing apparatus. Be fore anesthesia and positioning these physiological variables were similar in all rats at all plasma glu cose levels, except for the hypoglycemic rats (2-4 A. mM), which had a significantly lower arterial blood pH than those in the midnormoglycemic range (7-10 mM) (Table 1 ). Anesthesia and positioning had no apparent effects in rats with plasma glucose concen trations >5 mM, but caused the hypoglycemic ani mals to become slightly more acidotic, hypercap nic, and hypothermic compared with the midnor moglycemic rats (Table 1) .
DG and glucose distribution spaces and A for brain in normoglycemia
The steady-state distribution ratios of e4C]DG and glucose between brain and plasma and the val ues for J... were similar in all subgroups of the nor moglycemic rats, regardless of their treatment dur ing the positioning of the animals in the freeze blowing apparatus (i.e., celiac ganglionectomy and/ or thiopental anesthesia). The values in all were, therefore, averaged to obtain representative values for normoglycemic rats (Table 2) . Also, because the treatment of the animals during the positioning in the freeze-blowing apparatus had no significant ef fects on any of these variables in the normoglyce mic rats, the experiments in hypoglycemia and hy perglycemia were carried out in rats that were con- a Physiological variables were measured in arterial blood samples drawn during the glucose infusion just before the 45-min infusion of [14Cldeoxyglucose and after positioning the rats on the restrainer of the freeze-blowing apparatus. The number of rats/group is indicated in parentheses.
b p < 0.05; cp < 0.01; analysis of variance and Dunnett's test for multiple comparisons against the mid-normoglycemic group of rats (plasma glucose range, 7. 1-10.0 mM). The midnormoglycemic group is the combined mean of rats pooled from three experimental groups (celiac ganglionectomy, celiac ganglionectomy plus thiopental anesthesia, and thiopental anesthesia); the means of these groups were not statistically significantly different from each other.
scious during the simultaneous infusions of glucose and e4C]DG but lighly anesthetized with thiopental before positioning in the apparatus and killing. The distribution ratio is the brain concentration/plasma con centration; A is the [14Cldeoxyglucose distribution ratio/glucose distribution ratio. Values from three groups of rats, celiac gan glionectomy (n = 6), celiac ganglionectomy and thiopental an esthesia (n = 3), and thiopental anesthesia (n = 6) (see Materials and Methods) were not significantly different and are presented as combined means.
parallel with each other with changing steady-state plasma glucose concentrations (Fig. 2) . Brain glu cose concentrations and distribution ratios in the normoglycemic rats were similar to those previ ously reported in comparable rats (Cremer et aI., 1981 (Cremer et aI., , 1983 Crane et aI., 1985) . The brain glucose concentration changed more or less in proportion to plasma glucose concentration. On the other hand, [14C]DG concentration in brain tended to rise with decreasing plasma glucose concentration, but the increase was not monotonic; between �6 and 8 mM it appeared to reverse and decline before resuming its upward trend with decreasing plasma glucose concentration. In Fig. 2B there is a gap in the data between 6 and 8 mM, just where the reversal ap pears, which is due in part to the limited number of animals within this range. This discontinuity is not seen, however, in the plot of the distribution ratio for [14C]DG (Fig. 3B) because the plasma e4C]DG concentrations compensated for the changes in brain.
The steady-state brain:plasma distribution vol umes for glucose and e4C]DG also changed in op posite directions in hypoglycemia; the distribution volume for glucose fell while that for e4C]DG rose with decreasing plasma glucose levels (Figs. 3 and  4) . On the other hand, both showed progressive, moderate declines with increasing plasma glucose 
I:
.
• Thiopental Anesthesia concentration (Figs. 3 and 4) ; between 8 and 27 mM both distribution ratios were significantly nega tively correlated with the plasma glucose concen tration (r = -0.63, p < 0.005, and r = -0.92, p < 0.001, for glucose and DG, respectively). Thus, X. rose sharply when glucose levels fell below 4 mM in plasma (Fig. SA) or 0.4 fJ-molig in brain (Fig. SB) . In contrast, X. was relatively insensitive to hyperglyce mia (Fig. S) .
DISCUSSION
The present studies provide, to our knowledge, the first direct chemically measured values of glu cose concentration, the distribution spaces for glu cose and e4C]DG, and the X. of the lumped constant in brain experimentally clamped in steady states for both glucose and e4C]DG. The direct chemical measurements in the steady state makes these de terminations of X. essentially model-independent. Previous efforts to evaluate X. were indirect and highly dependent on the particular model employed and on estimates of the transfer constants for J Cereb Blood Flow Me/ab, Vol. 9, No. 3, 1989 e4C]DG and glucose transport back and forth be tween brain and plasma and on the rate constants for their phosphorylation by hexokinase in brain (Crane et aI., 1981; Cunningham and Cremer, 1981; Gj edde, 1982; Pardridge et aI., 1982a Pardridge et aI., , 1982b Par dridge, 1983; Pettigrew et aI., 1983) ; the values for X. obtained by these methods were, therefore, vulner able to imperfections in the model and uncertainties in the estimates of the transfer and rate constants that were generally determined in other animals. These previous studies did, however, predict that X. would decline relatively moderately in hyperglyce mia and rise precipitously in hypoglycemia (Crane et aI., 1981; Cunningham and Cremer, 1981; Gjedde, 1982; Pardridge et aI., 1982a Pardridge et aI., , 1982b Par dridge, 1983; Pettigrew et aI., 1983) . The results of the present studies confirm these predictions. The directly measured values for X. were found to be relatively stable over a wide range of arterial plasma glucose concentrations, declining very gradually with plasma glucose concentrations between S to 6 and 28 mM, and rising sharply when the glucose concentration fell below 4 mM. These variations in 0:: A with changing arterial plasma glucose concentra tion account for the experimentally measured changes in the lumped constant in hypoglycemia and hyperglycemia (Suda et aI., 1981; Schuier et aI., 1981; Pettigrew et aI., 1983) . The data acquired in the present studies also made it possible to define on the basis of direct chemical measurements the relationship between A and the brain glucose concentration. It is easily shown that A, as defined in the original description of the deoxyglucose method (Sokoloff et aI., 1977) , is a function of the kinetic constants for DG and glucose transport across the blood-brain barrier and for phosphorylation by hexokinase as well as the glucose concentration in the tissue (Cunning ham and Cremer, 1981; Gjedde, 1982; Pardridge, 1983) . If the values for the transfer and rate con stants are known and the brain glucose concentra tion is determined, then A can be evaluated. Gjedde and associates (Gjedde, 1982; Diemer and Gjedde, 1983; Gjedde and Diemer, 1983) have employed la-BRAIN GLUCOSE CONCENTRATION (J.lmol/g) beled 3-0-methyl-D-glucose to determine local con centrations of glucose in brain tissue by quantitative autoradiography and thereby estimate the local val ues of A. Their approach is highly dependent on the accuracy of the values of the kinetic constants. The relationship between A and brain tissue glucose con centration graphically represented in Fig. 5B allows empirical determination of A from glucose concen trations in brain tissue, however determined, with out dependence on unreliable estimated values of the kinetic constants for transport and phosphory lation of DG and glucose.
The lumped constant in the operational equation of the DG method (Sokoloff et aI., 1977) 
equals
A V�Km/<I> V mK�. <I> is a constant between 0 and 1 that represents the fraction of G-6-P that, once formed, continues down the glycolytic pathway; with the very low levels of G-6-Pase activy in the brain <I> is approximately equal to 1 and unlikely to change. V�Km/V mK�, the phosphorylation coeffi cient (Sols and Crane, 1954) , is the product of the 25 1 "'" I" " I" " I" " I" " I" " I" " I" " I "" I "" I "" I '" '1 18 ratios of the Michaelis-Menten maximal velocities and Km values of hexokinase for DG and glucose (* indicates values for DG); it represents the ratio of the phosphorylation potential of hexokinase for DG relative to that of glucose and is also likely to be a stable constant. It is only changes in }.. that could be expected to be responsible for the variation in the lumped constant with varying plasma and brain tis sue glucose concentrations. The phosphorylation coefficients at various plasma glucose concentra tions were calculated by dividing the values of the lumped constants previously measured over the full range from hypoglycemia through normoglycemia to hyperglycemia (Suda et aI., 1981; Schuier et aI., 1981; Pettigrew et aI., 1983) by the values of }.. at equivalent plasma glucose concentrations deter mined in the present studies. The values for the phosphorylation coefficient in the normoglycemic and hyperglycemic rats fell within the range of 0.21-0.26, values similar to or somewhat lower than J Cereb Blood Flow Metab, Vol. 9, No. 3, 1989 5.5 6.0 those previously estimated by other methods (Crane et aI., 1981; Cunningham and Cremer, 1981; Gj edde, 1982; Pardridge et aI., 1982b; Pardridge, 1983; Fuglsang et aI., 1986) . Unexpectedly, how ever, the phosphorylation coefficient appeared to decrease in hypoglycemia. There is no obvious ex planation why the true phosphorylation coefficient, which is composed of the Michaelis-Menten kinetic constants, should vary with plasma and/or brain glucose concentration. Also, the progressively in creasing free e4C]DG concentrations in brain (Fig.  2B) and the magnitude of the increases in the dis tribution space for e4C]DG and }.. with increasing severity of the hypoglycemia below plasma concen trations of 4 mM (Figs. 3B and SA) are inconsistent with the results of simulations based on kinetic analyses of the model of the DG method (J. E. Holden et aI., unpublished data). In fact, in several hypoglycemic rats the distribution spaces exceeded 1.0 (Fig. 3B) , and the }.. rose to IS-20 (Fig. SA) , values that should be impossible according to the results of these simulations.
A simplifying assumption of the original DG model is that all of the free e4C]DG and glucose in the brain are confined to a single common compart ment that represents the precursor pools for carrier mediated transport from tissue to plasma and phos phorylation by hexokinase (Sokoloff et aI. , 1977) . The high values for the distribution space for e4C]DG and the A could be explained if a portion of the [ 1 4C]DG were sequestered in some other un identified tissue compartment(s) and/or if extracel lular and intracellular compartmentation became sufficiently more significant with increasing sever ity of hypoglycemia to invalidate the simplifying as sumption. The total free [ 1 4C]DG concentration measured in extracts of whole brain would then overestimate the size of the true precursor pool for transport and phosphorylation. The apparent size of the true precursor pool might also be artifactually increased by metabolic or chemical instability of some metabolites of e4C]DG with subsequent re generation of free e4C]DG from them either in the brain during the experimental period or during the extraction procedure. The relative balance among the rates of the metabolic pathways by which e4C]DG is metabolized might change in hypoglyce mia, and the quantities of labile metabolites may be increased when competition with glucose and its derivatives is minimal. Both compartmentation and lability of metabolites of e4C]DG would lead to overestimates of its brain concentration and distri bution space and, therefore, also of A, which should represent only the true precursor pools of e4C]DG and glucose. An artifactually increasing A with in creasing hypoglycemia would then in turn lead to an apparent but also artifactual decreasing phosphory lation coefficient in hypoglycemia. Experiments to investigate these possibilities are currently in prog ress in our laboratory. Preliminary results thus far suggest that the free [ 1 4C]DG concentrations mea sured in the brains of hypoglycemic rats may indeed overestimate the true precursor pool, whereas those in normoglycemic and hyperglycemic rats ap pear to be close to their expected and predicted values. When this issue of the accuracy of the A and the phosphorylation coefficient in severe hypogly cemia is resolved, then it will become possible to determine the lumped constant from their values at any brain tissue glucose concentration.
